International expert consensus on laparoscopic pancreaticoduodenectomy by Qin, Renyi et al.
 
 
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
International expert consensus on laparoscopic
pancreaticoduodenectomy
Citation for published version:
Qin, R, Kendrick, ML, Wolfgang, CL, Edil, BH, Palanivelu, C, Parks, RW, Yang, Y, He, J, Zhang, T, Mou, Y,
Yu, X, Peng, B, Senthilnathan, P, Han, H-S, Lee, JH, Unno, M, Damink, SWMO, Bansal, VK, Chow, P,
Cheung, TT, Choi, N, Tien, Y-W, Wang, C, Fok, M, Cai, X, Zou, S, Peng, S & Zhao, Y 2020, 'International
expert consensus on laparoscopic pancreaticoduodenectomy', Hepatobiliary surgery and nutrition, vol. 9,
no. 4, pp. 464-483. https://doi.org/10.21037/hbsn-20-446
Digital Object Identifier (DOI):
10.21037/hbsn-20-446
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Hepatobiliary surgery and nutrition
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 04. Jan. 2021
© HepatoBiliary Surgery and Nutrition. All rights reserved.   HepatoBiliary Surg Nutr 2020;9(4):464-483 | http://dx.doi.org/10.21037/hbsn-20-446
Review Article
International expert consensus on laparoscopic 
pancreaticoduodenectomy*
Renyi Qin1, Michael L. Kendrick2, Christopher L. Wolfgang3, Barish H. Edil4, Chinnusamy Palanivelu5, 
Rowan W. Parks6, Yinmo Yang7, Jin He8, Taiping Zhang9, Yiping Mou10, Xianjun Yu11, Bing Peng12, 
Palanisamy Senthilnathan5, Ho-Seong Han13, Jae Hoon Lee14, Michiaki Unno15,  
Steven W. M. Olde Damink16, Virinder Kumar Bansal17, Pierce Chow18, Tan To Cheung19, Nim Choi20, 
Yu-Wen Tien21, Chengfeng Wang22, Manson Fok23, Xiujun Cai24, Shengquan Zou1, Shuyou Peng25,  
Yupei Zhao9
1Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 
Wuhan, China; 2Mayo Clinic, Rochester, MN, USA; 3Division of Surgical Oncology, Department of Surgery, The John Hopkins University 
School of Medicine, Baltimore, MD, USA; 4Department of Surgery, University of Oklahoma, Oklahoma City, OK, USA; 5Department of Surgical 
Gastroenterology and Hepatopancreatobiliary Surgery, GEM Hospital and Research Centre, Coimbatore, Tamil Nadu, India; 6Clinical Surgery, 
Royal Infirmary of Edinburgh and University of Edinburgh, Edinburgh, UK; 7Department of General Surgery, Peking University First Hospital, 
Beijing, China; 8Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA; 9Department of General Surgery, Peking 
Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 10Department of 
Gastroenterology and Pancreatic Surgery, Zhejiang Provincial People’s Hospital, Hangzhou Medical College, Hangzhou, China; 11Department 
of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; 12Department of Pancreatic Surgery, West 
China Hospital, Sichuan University, Chengdu, China; 13Department of Surgery, Seoul National University College of Medicine, Seoul National 
University Bundang Hospital, Seoul, Korea; 14Division of Hepatopancreatobiliary Surgery, Department of Surgery, Asan Medical Center, Seoul, 
Korea; 15Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan; 16Department of Surgery, NUTRIM School 
of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands; 17Department of 
Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India; 18Department of Hepatopancreatobiliary and Transplant Surgery, 
Singapore General Hospital, Singapore, Singapore; 19Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 
China; 20Department of General Surgery, Hospital Conde S. Januário, Macau, China; 21Department of Surgery, National Taiwan University Hospital 
and National Taiwan University College of Medicine, Taipei; 22Department of Pancreatic and Gastric Surgery, National Cancer Center/Cancer 
Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 23Department of Surgery, University Hospital, 
Macau University of Science and Technology, Macau, China; 24Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, 
Hangzhou, China; 25Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, 
Hangzhou, China
Contributions: (I) Conception and design: R Qin, Y Zhao; (II) Administrative support: R Qin, Y Zhao; (III) Provision of study materials or patients: 
R Qin, Y Zhao; (IV) Collection and assembly of data: R Qin, C Wang; (V) Data analysis and interpretation: R Qin, Y Zhao, S Peng, S Zou; (VI) 
Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
Correspondence to: Renyi Qin. Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of 
Science and Technology, Wuhan, China. Email: ryqin@tjh.tjmu.edu.cn; Yupei Zhao. Department of General Surgery, Peking Union Medical College 
Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Email: zhao8028@263.net.
Members of the Consensus Steering Committee: Renyi Qin, Yupei Zhao, Michael L. Kendrick, Christopher L. Wolfgang, Barish H. Edil, Chinnusamy 
Palanivelu, Shuyou Peng.
Members of the Consensus Development Committee: Rowan W. Parks, Yinmo Yang, Jin He, Taiping Zhang, Yiping Mou, Xianjun Yu, Bing Peng, 
Palanisamy Senthilnathan, Ho-Seong Han, Jae Hoon Lee, Michiaki Unno, Steven Olde Damink, Virinder Kumar Bansal, Pierce Chow, Tan To 
Cheung, Nim Choi, Yu-Wen Tien, Chengfeng Wang, Manson Fok, Xiujun Cai, Shengquan Zhou.
Members of the Consensus Secretary: Junfang Zhao, Hang Zhang, Min Wang.
483
*From The 1st Summit on Minimally Invasive Pancreatico-Biliary Surgery, Wuhan, China.
HepatoBiliary Surgery and Nutrition, Vol 9, No 4 August 2020 465
© HepatoBiliary Surgery and Nutrition. All rights reserved.   HepatoBiliary Surg Nutr 2020;9(4):464-483 | http://dx.doi.org/10.21037/hbsn-20-446
Introduction
Laparoscopic pancreaticoduodenectomy (LPD) was first 
reported by Gagner and Pomp in 1994 (1). Since then, more 
and more centers started carrying out this procedure not 
only in pancreatic cancer or periampullary malignancies, 
but also in benign disease or low-grade malignant neoplasm 
(2-5). However, LPD is still considered to be a technically 
demanding procedure because of the extensive dissection 
around critical anatomical structures and the complex 
reconstruction (6,7). Although there has been worldwide 
interest in adopting LPD, its safety and efficacy have 
not gained uniform acceptance (6,8,9). Most studies 
revealed favorable outcomes in larger volume centers, 
but a recent meta-analysis of randomized controlled trials 
(RCTs) showed that LPD shows no advantage over open 
pancreaticoduodenectomy (OPD) (6,10). Furthermore, 
the recent LEOPARD-2 trial reported 90-day mortality 
was even higher in the LPD group in a cohort of 50 vs. 
50 patients (11), resulting in a prematurely termination 
of this project because of safety concerns. Given the fact 
that increased mortality is not observed in all centers and 
that LPD is done safely by experienced surgeons in large 
volume centers (12-14), surgeon experience, learning curve, 
and annual volume are likely have large influence on the 
outcome.
Together with LPD, robotic pancreaticoduodenectomy 
(RPD) forms two major minimally invasive patterns of such 
complex procedure (15). RPD has been shown as a safe and 
feasible alternative to conservative pancreaticoduodenectomy 
in terms of perioperative outcomes (16). Even more, many 
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have the belief that RPD is even superior to LPD because of 
the advantages in digestive tract reconstruction. However, 
taken into account of increased cost (17) and the fact that 
RPD is not available in all countries and locations, it is 
important that some pancreatic centers must necessarily 
focus on LPD, but not RPD.
The European Association for Endoscopic Surgery 
consensus statement on LPD reported that it is feasible 
and safe in experienced hands; however, it should only be 
considered in selected cases and probably not in low-volume 
centers (18). While the theoretical benefits of LPD are clear, 
there is no clear consensus among the surgical community 
regarding its application. In order to advance LPD, an 
international panel of experts was convened at the 1st 
Summit on Minimally Invasive Pancreatico-Biliary Surgery 
in Wuhan, China. The present consensus statement on 
LPD was developed and aimed to provide guidance for both 
experienced and training surgeons, as well as for specialist 
institutions, regarding the appropriateness of care, in order 
to reduce variations in practice, and to facilitate the safe 
expansion of LPD with the goal of improving patient care.
We present the following article in accordance with the 
PRISMA reporting checklist (available at http://dx.doi.
org/10.21037/hbsn-20-446.
Methods
Selection of the expert panel
The members of the international expert panel were 
selected by the summit  chairman based on their 
publications in peer-reviewed journals and/or their 
significant contributions to the development of LPD. 
To diminish the bias that may cause from participated 
enthusiastic laparoscopic surgeons in the expert-panel, 
pancreatic surgeons who do not perform LPD were also 
invited to construct the panel. Twenty-eight members from 
eight countries constituted the expert panelists. Twenty-
one of them attended the one-day face-to-face meeting at 
the 1st Summit on Minimally Invasive Pancreatico-Biliary 
Surgery in Wuhan, China, which was held on the date from 
June 13th to June 15th, 2019. Other experts took part in the 
discussion by e-mail. The global distribution of participated 
experts is presented in Table S1.
Literature search and appraisal
The expert panel agreed on the list of topics to be included 
in the consensus conference. Each expert was assigned 
two or more topics and asked to prepare evidence-based 
statements supported by the current literature. The 
literature search and its critical appraisal were limited to 
articles published in English during the period from 1994 
to 2019. The Web of Science, Medline, and Cochrane 
Library and Clinical Trials databases were searched, 
The search strategy included, but was not limited to, 
the terms ‘laparoscopic’, ‘pancreaticoduodenectomy, 
‘pancreatoduodenectomy’, ‘Whipple’s operation’, and 
‘minimally invasive surgery’. Reference lists from the 
included articles were manually checked for any additional 
studies, which were included when appropriate. Critical 
appraisal of the literature was carried out using the evidence 
level provided by the Oxford Centre for Evidence-based 
Medicine (http://www.cebm.net/oxford-centre-evidence-
based-medicine-levels-evidence-march-2009/). Literature 
search and manual reference lists check were performed by 
the consensus secretary (JZ, HZ, and MW). Flow chart of 
the inclusion process is presented in Figure 1.
Selection of the topics
After a literature review and discussion by the consensus 
steering committee, five domains including 16 topics were 
identified: implementation, preoperative preparation, 
techniques, postoperative management and training. 
Each domain was further subdivided into certain topics. 
For example, the “implementation” domain was divided 
into “safety and feasibility”, “hospital volume”, “surgeon 
experience”, and “medical team”. All topics were sent 
to all expert panelists who were asked to either accept 
the statement or modify them. For the latter, a free text 
option was given to suggest detailed modifications or add 
new topics. Subjects with less than 80% agreement were 
considered inadequate. After the first round of surveys, 
modifications and additions were applied and a revised 
survey was sent out. Once consensus was reached, a draft 
document was compiled and sent out for final approval.
Consensus development
Upon reviewing the literature, the expert panelists drafted 
statements on a specific topic accompanied by a supporting 
discussion. All statements were combined and disseminated 
to the entire expert panel for voting in accordance with 
the Delphi methodology. This methodology allowed each 
expert to either agree or disagree with a given statement and 
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Figure 1 PRISMA diagram. Graphical representation of the publications that were reviewed in the process of generating this 
consensus statement. Three independent literature searches were performed, with each search including ‘(pancreatoduodenectomy OR 
pancreaticoduodenectomy) AND laparoscopic’. Level of evidence was graded according to the Oxford Centre for Evidence-based Medicine 
from 1 to 5.
1,577 potentially relevant articles identified after 
excluding duplicates
1,052 in ISI Web of knowledge
655 in PubMed/Medline
153 in the Cochrane Collaboration database
13 in ClinicalTrials.gov
502 full-text articles extracted for detailed 
assessment
1,075 articles excluded after screening of their 
titles and abstract
271 articles excluded
50 not in English
28 case reports with small number of patients
193 with irrelevant topics
231 articles included in developing the consensus 
92 graded as level 5
71 graded as level 4
32 graded as level 3b
25 graded as level 3a
8 graded as level 2c
2 graded as level 2b
1 graded as level 1b
make recommendations for changes to the statement if they 
consider it necessary. These statements were assessed by the 
members of the expert panel by email, and all response were 
sent back to the steering committee (first Delphi round). 
After statistical analysis, the statements with less than 80% 
agreement or new statements suggested by more than two 
experts were modified and put in circulation for further 
evaluation (second Delphi round). Based on the comments 
and suggestions, the consensus steering committee decided 
on the final statements and composed the first draft. The 
first draft was sent to all the experts who provided their 
responses by email. All statements were approved at a one-
day face-to-face meeting held at the 1st Summit on Minimally 
Invasive Pancreatico-Biliary Surgery in Wuhan, China. The 
final version of the manuscript was reviewed and approved 
by all participants involved in developing this statement. 
Of each statement, the quality of evidence and strength of 
recommendation were assessed applying GRADE approach. 
A summary of these topics, statements, quality of evidence, 
and recommendations is presented in Table S2.
Grading of evidence and definitions
After data extraction, the teams created a presentation 
on their topic and drafted a more comprehensive text 
summary of their findings. This process was conducted 
according to two validated methods: the Delphi method 
(for establishing expert consensus) and the AGREE II-
Global Rating Scale (GRS) Instrument (for the assessment 
of methodological quality and external validation of the 
final statements) (19). The final version of the manuscript 
was reviewed and approved by all experts involved in 
developing a final statement. We should be aware that 
with Delphi methodology, the sample size of participated 
experts was relatively small, which may result in potential 
bias when selecting topics and making statements, 
however, all topics were open for full discussion within the 
steering committee, and statements were drew based on 
evidence in literature.
Statistical analysis
Data collected during each round of the survey were 
analyzed for internal consistency using Cronbach’s alpha. 
Medians and interquartile ranges of responses from panel 
members were calculated for all survey items. Responses 
to items on a categorical scale (yes/no) were analyzed as 
percentage responses. Statistical analysis was performed 
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using SPSS version 20.0 (IBM Corp., Armonk, NY, USA).
Results
Section 1: Implementation
Topic 1: Safety and feasibility
Statement: LPD is safe and feasible compared with 
OPD, when performed in large volume medical centers 
by experienced surgeons. LPD is associated with a 
longer operative time, less intraoperative blood loss, 
and shorter length of stay (LOS) than OPD, while its 
overall complication and perioperative mortality rates are 
equivalent.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
In 1994, Gagner and Pomp reported their first 
experience in performing LPD, and concluded that 
laparoscopic Whipple procedure was technically feasible, 
but may not improve the postoperative outcome or shorten 
the postoperative recovery period (1). Since then, an 
increasing number of LPD have been subsequently carried 
out and their safety and feasibility have continued to be 
discussed.
Some studies have shown that LPD may be either less safe 
or confers no advantage over OPD. Cuschieri reported his 
disappointing experience with LPD for periampullary cancer 
and did not observe any benefit from this approach (20). 
Dokmak et al. found that LPD was associated with higher 
morbidity in a series of 46 patients with a higher incidence 
of severe postoperative pancreatic fistula (POPF) (28% 
vs. 20%, P=0.32) (21). van Hilst et al. reported that, 
although not statistically significant, LPD was associated 
with more complication-related deaths than OPD [5/50 
(10%) patients in the LPD group vs. 1/49 (2%) in the 
OPD group; risk ratio, 4.90; 95% confidence interval 
(CI), 0.59–40.44; P=0.20]. Furthermore, there was no 
difference between groups in time to functional recovery 
in their multicenter RCT (11). As the operative technique 
continued to develop and more cases were accumulated, 
an increasing amount of data demonstrated that LPD was 
not inferior to OPD. Nickel et al. reported no significant 
difference in 90-day mortality, Clavien-Dindo grade ≥III 
complications, LOS, POPF, delayed gastric emptying 
(DGE), postpancreatectomy hemorrhage (PPH), bile leak, 
reoperation, readmission, or oncologic outcomes between 
LPD and OPD (6). Ausania et al. found no statistically 
significant differences between LPD and OPD in terms of 
postoperative complications and mortality (13). Stauffer 
et al. reported that LPD provided similar short-term 
outcomes and long-term survival to OPD in the treatment 
of pancreatic ductal adenocarcinoma (PDAC) (22).
In recent years, the vast majority of studies conducted 
at high-volume centers demonstrated that LPD is 
feasible, safe and effective. Palanivelu et al. showed that 
LPD allowed a shorter LOS than OPD (7 vs. 13 days; 
P=0.001) (14). This trial was closely followed by a study 
from Poves et al. that demonstrated LPD was associated 
with a shorter LOS (median 13.5 vs. 17 days; P=0.024) 
and a more favorable postoperative course than OPD 
while maintaining the oncological standards of a curative-
intent surgical resection (8). A systematic review and 
meta-analysis showed that LPD was associated with 
longer disease-free survival than OPD (23). Chen et al. 
found that the 3-year [odds ratio (OR), 1.50; 95% CI, 
1.12–2.02; P=0.007], 4-year (OR, 1.73; 95% CI, 1.02–2.93; 
P=0.04), and 5-year overall survival (OR, 2.11; 95% CI, 
1.35–3.31; P=0.001) were significantly longer in the LPD 
group compared with the OPD group (24). Meng et al. 
reported that LPD was a feasible, safe, and effective 
method for the treatment of non-pancreatic periampullary 
adenocarcinoma and may be preferable to OPD (25). 
Klompmaker et al. affirmed the effectiveness and safety of 
LPD in a multinational, propensity-matched comparative 
study (7). All in all, LPD is feasible and safe in experienced 
hands.
Topic 2: Volume of pancreatic center and LPD
Statement: LPD should be carried out in pancreatic center 
with at least 25 cases of OPD per year. In addition, a robust 
radiology department and experienced interventionalists, 
as well as the pathology and anesthesiology departments, 
should also work closely together in order to carry out the 
surgery successfully.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
Although the safety and feasibility of LPD are becoming 
increasingly accepted, it is not recommended that all 
hospitals routinely perform LPD surgery. In a comparative 
study of patients who underwent OPD (n=14) and LPD 
(n=14) for benign and malignant indications at a single 
institution, Zureikat et al. concluded that LPD could 
be safely and feasibly implemented at a high-volume 
pancreatic surgery center without subjecting patients to an 
unacceptably higher risk of complications or compromising 
oncologic surgical principles (26). Qin et al. performed 
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a meta-analysis and suggested that LPD should only be 
performed at high-volume pancreatic surgery centers (27). 
Kutlu et al. investigated the relationship between the 
hospital volume of LPD and morbidity, mortality, and 
oncologic quality using the American National Cancer 
Data Base. They confirmed that the risk of postoperative 
mortality and suboptimal oncologic quality following LPD 
are higher in low-volume hospitals, and suggested that 
the putative benefits of LPD are likely to be observed in 
institutions performing ≥25 PD per year (28). In another 
large American National Cancer Data Base study of 4,421 
patients who underwent OPD (4,067, 91%) and LPD (384, 
9%), Sharpe et al. concluded that higher hospital volume 
was associated with a lower risk of 30-day mortality. In 
institutions that performed ≥10 LPD, the 30-day mortality 
rate of the laparoscopic approach was equal to that of the 
open approach (29). Wang et al. reviewed 1,029 LPD and 
concluded that higher hospital and surgeon volume, as well 
as surgeon experience with minimally invasive surgery, were 
associated with a lower risk of surgical failure (defined as a 
composition of 30-day mortality, conversion to laparotomy 
and postoperative complications with Clavien-Dindo 
≥III) (12). Klompmaker et al. performed a retrospective 
propensity score-matched study of minimally invasive 
pancreaticoduodenectomy (MIPD) across 14 European 
centers. In centers performing ≥10 MIPD annually, no 
differences were found in major morbidity, mortality, and 
LOS between LPD and OPD (7). In a systematic review 
of 26 MIPD and OPD comparative trials, Kendrick 
et al. reported that an excessive mortality after MIPD was 
associated with low-volume (<5 MIPD/year) hospitals. 
Among hospitals performing ≥5 MIPD/year, there were no 
mortality after MIPD, which was similar to the outcome of 
OPD (30). Senthilnathan et al. summarized their 15-year 
experience and reported that LPD has the potential to 
become the standard of care for patients with selected 
periampullary and pancreatic head tumors with acceptable 
oncological outcome, especially at high-volume centers (31). 
In general, it is recommended that LPD is restricted to 
high-volume centers, not only for the surgical experience, 
but also for the availability of multidisciplinary care.
Topic 3: Surgeon’s experience and LPD
Statement: In order to perform LPD successfully, surgeons 
should meet the following criteria: (I) Surgeons should 
have advanced laparoscopic skills. Advancement through 
the learning curve of minimally invasive surgery from basic 
to complex procedures, and mastering basic laparoscopic 
skills, such as dissection, suturing, and knotting, is essential 
before starting to perform LPD. (II) Experienced in OPD. 
Surgeons and teams intending to adopt LPD should first be 
proficient in OPD with each individual having a cumulative 
experience of >50 cases.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
In addition to the volume of the medical center, the 
surgeon’s experience and laparoscopic skills make an 
important contribution to performing LPD successfully. 
Sharpe et al. demonstrated a two-fold increase in the rate of 
perioperative mortality compared with OPD among surgeons 
performing <10 LPD within 2 years. These results may be 
attributed to the early learning curve in these surgeons (29). 
Hence, before performing LPD, surgeons should obtain 
structured training, carefully plan and consider the type of 
surgery, to minimize the risk to the patients (32,33). Wang 
et al. concluded that the criteria for credentialing surgeons 
to perform LPD should have more experiences not only 
in OPD, but also minimally invasive surgery in general. In 
fact, experience in minimally invasive surgery was the only 
factor associated with operative failure (12). Nagakawa et al. 
concluded that surgeons need more than 30 cases to achieve 
a stable performance for LPD. They particularly commented 
that procedures requiring more demanding skills, such as 
radical lymph node dissection, should be avoided during 
the introductory period (34). Coelho et al. advocated that 
LPD procedures should be performed by surgeons with 
extensive experience in open and laparoscopic biliary and 
pancreatic surgery (35). Kendrick et al. concluded that 
LPD with major venous resection is also feasible in selected 
patients, if extensive experience with complex laparoscopic 
pancreatic resection and reconstruction has been gained 
before attempting this procedure (36). Later, the same group 
reported that it was important to have performed at least 
50 OPD prior to embarking in MIPD. However, it was also 
mentioned that at a few high-volume centers with formal 
MIPD training programs, the required OPD volume may be 
significantly less (30).
Topic 4: Surgical team and LPD
Statement: The operating surgeon, assistant surgeon, 
anesthesiologist, and nursing team for LPD should be 
relatively fixed.
Quality of evidence: Low.
Level of recommendation: Weak.
Currently, there are no studies focusing on whether 
change in the composition of the surgical team impacts the 
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effectiveness of surgery between LPD and OPD. However, 
in general, better familiarity and expertise seemed to related 
with shorter operative time (37,38). Therefore, a stable 
surgical team, including operating and assistant surgeons, 
nurses, and anesthesiologist, who can work together 
consistently, is recommended. This could overcome the 
learning curve in a shorter period of time (39-41). In 
addition, two-operative surgeon model has been shown as 
a safe and feasible alternative to conventional operative-
assistant surgeon model in LPD (42).
Section 2: Indications, contraindications, and preoperative 
preparation
Topic 5: Indications
Statement: Indications of LPD could be similar to those 
of OPD, and should be determined by a multidisciplinary 
team (MDT) discussion before surgery, with careful 
consideration of the stage of the learning curve at which the 
surgeon is located.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
Postoperative outcomes after LPD are obviously 
associated with a learning curve (12) .  Thus,  i t  is 
recommended to conduct a MDT discussion before surgery 
to identify the indications of LPD (43-46). According 
to the stage of the learning curve, the following case 
selection and stepwise expansion of surgical indications are 
proposed (6,34,47): (I) in the initial period of the learning 
curve: after extensive simulation and step-by-step training, 
periampullary tumors with a clear tissue structure and no 
vascular compression should be selected. Patients should 
have no history of previous upper abdominal surgery and 
have lower body mass index (BMI ≤25.0 kg/m2). For total 
LPD, it is recommended to select patients with a pancreatic 
duct diameter ≥3 mm and a bile duct diameter ≥10 mm; 
(II) in the technical competency period: it is recommended 
that tumors around the ampulla without vascular invasion 
are selected, as well as benign pancreatic tumors without 
vascular compression; (III) in the challenging cases period: 
the indications for LPD can be gradually expanded to 
mirror those of OPD since the surgeons are considered to 
have fully overcome the learning curve by this period. For 
instance, for LPD with venous resection and reconstruction: 
although only reported in a small number of patients, 
these cases should only be considered by an experienced 
minimally invasive surgical team to achieve good long-
term outcomes in well-selected patients (48). Wang 
et al. classified the pancreatic head cancer into eight types 
with the aim of guiding surgeons in making the optimized 
operative decisions (49), although it is of interest to apply 
this system in the guidance of selecting more appropriate 
cases for LPD, this still need to be further studied in a 
prospective cohort.
Apart from strict control of indications, standardized 
training and education should be guaranteed to ensure 
safe and stable development of LPD (50). In selected 
patients, LPD in the hands of experienced surgeons offers 
advantages over open surgery without compromising the 
oncologic principles (51). With improvement in LPD 
technique, the indications will be extended to patients with 
vascular invasion. For LPD with venous resection and 
reconstruction, vascular grafts are more frequently needed, 
because adequate mobilization is not easy to be performed 
under laparoscopy, and vascular grafts can facilitate the safe 
reconstruction (2).
Wang et al. reported that the cases who proceeded to 
laparoscopic surgery should fulfill the following criteria: 
tumor diameter <4 cm, with no signs of peripheral 
vascular invasion, distant metastasis, or evident lymph 
node swelling (52). Bausch and Keck agreed that LPD 
is in particular suitable for the treatment of benign or 
premalignant tumors of the pancreatic head (5). Another 
group selected patients for LPD who met the following 
criteria: (I) BMI <28.0 kg/m2; (II) ampullary tumors, 
duodenal tumors restricted to the second part of the 
duodenum, lower common bile duct tumors, and PDAC of 
the pancreatic head; (III) chronic pancreatitis with mass in 
the pancreatic head and poor response after conservative 
treatment; and (IV) resectable, based on evaluation 
of professional radiologists and experienced surgeons 
thorough assessment of preoperative radiology (53).
Topic 6: Contraindications
Statement: Contraindications of LPD could be similar 
to those of OPD, in addition to some laparoscopic 
contraindications.
Quality of evidence: Moderate.
Strength of recommendation: Weak.
Besides the invasive extent of  malignancy,  the 
contraindications of LPD included morbid obesity (BMI 
≥40 kg/m2) (54-57), particularly unusual anatomy (e.g., 
a duodenum and pancreatic head residing in the true 
pelvis), and previous surgery with documented extensive 
adhesive disease (frozen abdomen) (39). Moreover, LPD 
is also contraindicated in patients that are deemed by the 
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MDT to be incapable of tolerating the anesthesia for 
pneumoperitoneum (such as those with severe chronic 
hepatic, renal, pulmonary, or cardiac disease) (58-60).
After thorough training and accumulation of surgical 
experience, the contraindications to LPD will likely be 
adjusted to mirror those of OPD (18). For instance, patients 
with metastatic disease (10,61-65); those with acute or 
chronic pancreatitis, widespread adhesions in the abdominal 
cavity, difficulty in exposing and separating the pancreas, or 
failure of establishing pneumoperitoneum (61-65); and those 
with lesions over than 180 degrees of superior mesenteric 
artery encasement, any celiac abutment, unreconstructible 
superior mesenteric vein/portal occlusion, or aortic invasion 
or encasement (7,15,25,36,59,60,66). It should be kept in 
mind that cases that are considered candidates for LPD at 
the late stage of learning curve may not be suitable in the 
early period.
Topic 7: Preoperative preparation
Statement: The preoperative preparation for LPD patients 
are consistent with those for OPD patients. Surgeons per 
se should also be prepared with proficient surgical skills for 
reducing the rate of conversion to laparotomy.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
In terms of general assessment, patients must be 
examined to ensure that they have no obvious heart, lung, 
kidney, or other major organ dysfunction, and no obvious 
surgical contraindications. Before surgery, any anemia, 
hypoalbuminemia, and acid-base or metabolic disorders 
should be corrected, and nutritional status should be 
optimized. The decision to perform preoperative biliary 
drainage for jaundice is at the discretion of each center 
(28,67). Neoadjuvant chemotherapy is considered and 
administered according to the same principles as OPD (68).
Careful examination of local lesions with imaging studies 
(including ultrasound, multi-phase contrast-enhanced CT, 
and MRI, etc.) is necessary to comprehensively understand 
the tumor size, location, relationship with peripheral blood 
vessels, and whether there are vascular variations (especially 
of the proper hepatic artery). For patients with an uncertain 
diagnosis, endoscopic ultrasound-guided biopsy, positron 
emission tomography-CT, and other further investigations 
should be considered. Although carrying out the relevant 
preoperative investigations to obtain a pathological 
diagnosis has been advocated, a definitive pathological 
diagnosis before surgery is not required (69).
The principle of conversion from LPD to OPD 
including reasons of active or passive. Apart from adequate 
preparations of operated patients, surgeons per se should 
be prepared with proficient surgical skills by overcoming 
learning curve with the aim of reducing rate of active/
passive conversion to laparotomy, because postoperative 
outcomes after LPD were obviously associated with a 
learning curve (12), and patients who have a conversion 
often have a poorer prognosis than totally LPD.
Section 3: Technique
Topic 8: Types of LPD
Statement: There are four types of LPD: Total, hand-
assisted, laparoscopy-assisted, and robotic-assistance. Each 
is defined below. The choice of operative approach should 
be made in accordance with the stage of learning cure at 
which the surgeon is located. Robotic surgery for LPD 
may offer several advantages, especially for digestive tract 
reconstruction. However, due to its high cost, it is not 
widely utilized.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
LPD includes (I) total LPD, where both resection 
and gastrointestinal reconstruction are completed 
laparoscopically; (II) hand-assisted LPD (HALPD), where 
a hand port or a mini-incision is added to facilitate the 
procedure; (III) laparoscopy-assisted PD (LAPD), in which 
dissection is performed laparoscopically and reconstruction 
is completed through a small mini-laparotomy incision; 
and (IV) robotic-assisted pancreaticoduodenectomy 
(RAPD), where dissection is performed laparoscopically 
and reconstruction is completed using the surgical system 
(62,70).
Total LPD is the most common type of LPD. Its 
l imitations can be attributed to the complexity of 
performing gastrointestinal reconstruction laparoscopically. 
To overcome these shortcomings, HALPD and LAPD 
are recommended, and can serve as a bridge from open 
to laparoscopic surgery during the learning curve (71). 
Robotic assistance surgery theoretically offers several 
advantages, including a clear, three-dimensional image, 
high magnification of the operation field, and flexible arms 
and wrists. There is increasing evidence that RAPD can 
be performed safely in selected patients, but there is no 
definitive proof that it translates into reduced morbidity, 
mostly because of the unsolved problem of POPF (72,73). 
Zhao et al. found that RAPD is a safe and feasible alternative 
to OPD in terms of perioperative outcomes. However, 
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due to the lack of high-quality RCT, the evidence is still 
limited (16). Zhang et al. reported that both LPD and 
RAPD were technically feasible and had comparable short-
term results in experienced hands. There are steep learning 
curves for both LPD and RAPD. However, the learning 
curve of RAPD seems shorter. And large-scale clinical trials 
are still needed to compare the long-term outcomes of 
LPD and RAPD (17). The current evidence suggested that 
robotic approach has a longer operative time and higher 
costs compared with the laparoscopic approach (17).
Topic 9: The approach to resection during LPD
Statement: The principles of tumor resection by LPD 
should be similar to those of standard OPD for different 
types of cancer. Short-term oncologic outcomes (harvested 
lymph nodes/positive resection margins) are comparable 
between LPD and OPD.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
Data on the oncologic outcomes of LPD are insufficient. 
Of five meta-analyses focusing on minimal invasive 
pancreaticoduodenectomy and OPD, only two found 
significant differences in terms of the total number of 
harvested lymph nodes and the rate of positive resection 
margins (10,74). Correa-Gallego et al. reported more lymph 
nodes harvested and a higher rate of negative margins 
following MIPD (74), whereas de Rooij and co-workers 
found no differences in the total number of retrieved lymph 
nodes but observed a lower rate of positive margins in the 
minimal invasive pancreaticoduodenectomy group (10). 
Poves et al. and Palanivelu et al. also demonstrated that there 
was no significant difference in the number of lymph nodes 
retrieved or resection margins between the two approaches 
(8,62). Two comparative studies reported that a greater 
number of lymph nodes were retrieved during LPD (75). 
Croome et al. found that LPD was more effective in 
securing surgical margins than OPD in patients requiring 
major vascular resection (75). Cai et al. and Palanisamy et al. 
suggested that major venous resection and reconstruction 
can be performed safely by LPD (66,76). In a matched 
case-control study, Song et al. found no differences in 
survival among patients with periampullary cancer that 
underwent LPD or OPD (77). Palanivelu et al. reported 
a 5-year survival of 32% in patients with periampullary 
cancer following LPD (62). Another study from the same 
center reported 5-year survival of 29.4% in patients with 
PDAC (31). However, both studies included only patients 
with early-stage cancer (T1–2, N0–1, M0). Comparative 
studies of LPD and OPD for PDAC found no statistically 
significant differences in survival (78,79). These findings 
were subsequently confirmed by Croome et al. (75).
Topic 10: Gastrointestinal reconstruction during LPD
Statement: The reconstruction phase during LPD is 
especially technically demanding and time-consuming, 
taking longer than that during OPD. However, the 
morbidity associated with gastrointestinal reconstruction is 
comparable between LPD and OPD.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
LPD often takes significantly longer operating time 
than OPD (12,13,80). A previous meta-analysis found no 
difference between LPD and OPD in terms of overall 
morbidity associated with gastrointestinal reconstruction, 
such as the rates of POPF and clinically relevant POPF, 
bile or gastrointestinal leakage (13). On the other hand, de 
Rooij et al. reported a significantly lower rate of delayed 
gastric empty after LPD (10). Some comparative studies 
also reported similar morbidity (77,80,81) and POPF 
rates after LPD and OPD (77,80-83). However, Dokmak 
et al. observed significantly more grade C POPF in the 
laparoscopic group (21).
Management of the pancreatic stump is the most 
complicated step during digestive tract reconstruction. 
Although pancreaticojejunostomy (PJ) is more commonly 
performed than pancreaticogastrostomy, many surgeons 
have the belief that both PJ and pancreaticogastrostomy 
were safe reconstructive approaches, and that the choice 
between them would depend on preference of surgeons (84). 
Two-layer duct-to-mucosal anastomosis is the most 
common form of PJ, but other modified methods have also 
been reported, including single-row, invaginated, dunking, 
sleeving-joint, end-to-end, and binding PJ (7,85-90). Some 
modifications of duct-to-mucosal PJ were associated with 
reduced rates of POPF and postoperative complications, 
for instance, Blumgart anastomosis (83,91) and Bing’s 
anastomosis (90). Similarly, certain modifications of 
pancreaticogastrostomy were also shown as safe and feasible 
procedures (92,93).
Several techniques that do not involve suturing of the 
main pancreatic duct to the mucosa of the jejunum, which 
may shorten the PJ time, have been reported, and larger 
prospective cohort series and RCTs are warranted to 
validate them (94). Lu et al. reported that end-to-end PJ 
was associated with a low rate of pancreatic leakage, while 
none of the patients who underwent a duct-to-jejunal end-
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to-side embedding PJ developed leakage (87). Hughes 
et al. presented a less technically demanding PJ technique 
that creates an end-to-end intussuscepting anastomosis 
using a running monofilament suture (89). Nakamura 
et al.’s method of PJ with closure of the pancreatic stump 
by an endoscopic linear stapler was shown to be feasible 
during LPD with positive short-term results (95). Kim et al. 
demonstrated that their novel technique of PJ using only 
two transpancreatic buttress sutures is a simple method 
suitable for total LPD, which can reduce the burden on 
the surgeon and achieve a secure anastomosis (85). Hong’s 
single-stitch duct-to-mucosa PJ could not only reduce the 
incidence of clinically relevant POPF, but also shorten the 
operation time (96). The imbedding duct-to-mucosa PJ 
was found to be a simple and safe reconstruction approach 
in a series of patients reported by Wang et al., especially 
in patients with a nondilated pancreatic duct (94). Lei 
et al. demonstrated that their asymmetric sleeving-joint 
technique facilitated PJ, both laparoscopically and during 
open surgery (88).
Section 4: Postoperative management and follow-up
Topic 11: Postoperative morbidity
Statement: LPD, although complicated and technically 
demanding, is safe and effective in the hands of experienced 
surgeons. The rate of complications in patients who 
undergo LPD is equivalent to those who undergo OPD. 
Moreover, patients benefit from the laparoscopic approach 
with respect to reduced blood loss and surgical site 
infections, and a shortened hospital stay.
Quality of evidence: High.
Strength of recommendation: Strong.
The precise differences in postoperative morbidity 
between LPD and OPD remain controversial, with most 
studies reporting comparable rates. Meta-analysis of the 
only three RCTs performed showed that there were no 
significant differences in 90-day mortality, Clavien-Dindo 
grade ≥III complications, LOS, POPF, DGE, PPH, bile 
leak, reoperation, readmission, or oncologic outcomes 
between LPD and OPD. Operation time was significantly 
longer, but blood loss was less with LPD (median difference, 
–151 mL; 95% CI, –168.5 to –133.4 mL), although the 
certainty of evidence was moderate to very low (6). A 
previous meta-analysis of retrospective studies also showed 
that the rate of overall morbidity, POPF, reoperations, 
DGE, and PPH, were comparable between LPD and OPD 
(74,97).
A recent study by van Hilst et al. showed that the 
complication rate after LPD was equivalent to that after 
OPD, with similar functional recovery time (median, 10 
vs. 8 days, P=0.80), and Clavien-Dindo grade III or higher 
complications rate (25 of 50 patients vs. 19 of 49 patients, 
P=0.26) (11). There were similar findings in two other 
studies (8,14). In terms of the most major complications, 
such as POPF, DGE, and PPH, most of the research 
showed that there was no significant difference between 
the different procedures. Song et al. found comparable 
POPF and DGE rates in a matched case-control cohort 
study comparing laparoscopic and open pylorus-
preserving pancreaticoduodenectomy in patients with 
periampullary tumors (77). Liang et al. reported that the 
major complication (Clavien-Dindo ≥III) rates were not 
significantly different (33% for LPD vs. 17% for OPD), but 
a trend towards more re-operations after LPD was found 
when compared with OPD (20% vs. 3%; P=0.07) (98). 
Compared to OPD, LPD took longer time to perform, 
but no differences in blood loss, morbidity, mortality, R0 
resection rate, and lymph node harvest were noted (98). 
Kuesters et al. also found no difference in postoperative 
mortality and morbidity between LPD and OPD in their 
study, however, patients in the LPD group tended to have 
a lower BMI (23 vs. 27 kg/m2, P<0.001) and a greater 
proportion had a soft pancreas (57% vs. 47%, P=0.38), 
but there were no differences in associated comorbidities 
or underlying disease (59). Similarly, Jiang et al. showed 
no significant difference in operative time, intraoperative 
blood loss, the rate of conversion to OPD, postoperative 
complications, mortality, or the number of lymph nodes 
retrieved during surgery for malignancy (99).
Moreover, compared with OPD, LPD has beneficial 
effects on wound healing, as evidenced in a decreased 
surgical site infection rate (39,100). Total LPD was 
associated with lower rates of intra-abdominal abscess (0% 
vs. 16.0%, P=0.049), but there were no differences in POPF, 
bile leak, DGE, wound infection, LOS, and readmission 
(all P>0.05) (101). In contrast, some studies showed that 
LOS was shorter in the LPD group (29,74,77,102). LPD 
was also associated with a reduced blood loss (74), which 
was confirmed in two independent meta-analysis (82,102). 
Although not statistically significant, Dokmak et al. reported 
that both mortality (2.1% vs. 0%, P=0.28) and severe 
morbidity were higher in the LPD group (28% vs. 20%, 
P=0.32), due to the higher incidence of grade C POPF 
(24% vs. 6%, P=0.007), bleeding (24% vs. 7%, P=0.02), and 
revision surgery (24% vs. 11%, P=0.09) (21). In a meta-
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analysis of 1,196 patients with LPD and 8,247 with OPD 
from 11 identified studies, the pooled data showed that 
LPD was associated with less morbidity, less blood loss, 
shorter LOS, while comparable POPF and overall survival 
rates to OPD. As regards postoperative complications, LPD 
was associated with reduced rates of clinically relevant grade 
B/C POPF (15% vs. 36%; P=0.036) and grade B/C DGE 
(8% vs. 20%; P=0.049) (103). A comparative study has 
suggested that LPD is associated with decreased blood loss, 
longer operative time, similar post-operative complication 
rate, decreased pain, and shorter LOS, and there was no 
difference in the incidence of POPF, blood loss, return to 
diet and lymph node harvest (97). However, another meta-
analysis found that laparoscopic pylorus-preserving PD was 
associated with a shorter LOS (P=0.0003) and a tendency 
towards lower rates of DGE, although with a longer 
operation time (P=0.02) (104). Furthermore, minimally 
invasive approaches were associated with significantly 
decreased morbidity in early stage tumors (stage zero-II) 
(51.3% vs. 56.2%, P=0.03) and advanced stage disease (stage 
III–IV) (50% vs. 60.3%, P=0.04) (105). The rate of major 
postoperative complications (Clavien-Dindo ≥III) was 29% 
after LPD and 31% after OPD [relative risk (RR), 0.80; 
95% CI, 0.36–1.79; P=0.592].
Unless performed by highly skilled surgeons (106), 
LPD generally required a longer operative time than 
OPD (10,29,67,74,77,107). Chen et al. reported that while 
the operative time was longer for LPD (weighted mean 
difference 87.68 min; 95% CI, 27.05–148.32; P<0.01), the 
R0 rate tended to be higher (OR, 1.17; 95% CI, 1.00–1.37, 
P=0.05) and there tended to be more lymph nodes retrieved 
(weighted mean difference 1.15; 95% CI, –0.16 to –2.47, 
P=0.08), but these differences failed to reach statistical 
significance (82). These findings confirm that the risks of 
postoperative mortality and suboptimal oncologic quality 
are higher at low-volume hospitals. Furthermore, these 
risks are more profound with LPD compared with OPD. 
These data suggest that the putative benefits from LPD are 
unlikely to be observed at institutions performing less than 
25 PD per year (28). In an overall analysis of a cohort of 
patients, POPF was more common after LPD, but it should 
be noted that the proportion of ampullary adenocarcinoma 
(25% vs. 10%, P=0.004) and soft pancreatic parenchyma 
(52% vs. 38%, P=0.001) were also higher in that group. 
After matching (n=65), LPD was found to be associated 
with longer operative time (429 vs. 328 min, P<0.001) and 
less blood loss (370 vs. 515 mL, P=0.047). The rate and 
severity of POPF were similar (33% vs. 27%, P=0.439 
and P=0.083) in the two matched groups. However, both 
total (78% vs. 71%, P=0.030) and major complications 
(40% vs. 23%, P=0.033) were more frequent in the LPD 
group. Patients that underwent LPD experienced more 
postoperative bleeding (21% vs. 14%, P=0.025) than those 
who underwent open surgery. In a multivariate analysis, 
perioperative transfusion (OR, 5; 95% CI, 1.5–16; P=0.008), 
soft pancreas (OR, 2.5; 95% CI, 1.4–4.6; P=0.001), and 
ampullary adenocarcinoma (OR, 2.6; 95% CI, 1.2–5.6; 
P=0.015) were identified as independent risks factors for 
major complications (108).
Study dedicated into illuminating the advantage of 
applying enhanced recovery after surgery (ERAS) in LPD 
has not be seen in literature so far. However, it has been 
reported that laparoscopic digestive system surgery within 
an ERAS protocol led to better immunity preservation (109), 
faster postoperative rehabilitation, shorter LOS and lower 
rate of postoperative complications (110). Therefore, 
further study on this important topic is needed.
Topic 12: Postoperative mortality
Statement: The mortality rate after LPD is a significant 
safety concern. Therefore, LPD should only be performed 
by skilled laparoscopic surgeons with proper training 
in high-volume pancreatic centers. Further large trials 
involving well-trained laparoscopic surgeons at high-volume 
hospitals are needed to clarify this concern.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
A recent  meta-analys is  of  RCTs reported that 
complication-related mortality occurred in 5% of the LPD 
group and 4% of the OPD group (RR, 1.22; 95% CI, 0.19–
8.02; P=0.841) (13). However, in a retrospective analysis 
of a large dataset, LPD was shown to be as associated 
with increased 30-day mortality (OR, 1.89; P=0.009), 
although the authors highlighted that this observation 
could be driven by a surmountable learning curve (29). 
Moreover, although the differences were not statistically 
significant, a recent trial by van Hilst et al. revealed that 
90-day mortality after LPD was higher than after OPD (5 
of 50 vs. 1 of 49; RR 4.9, 95% CI, 0.59–40.44; P=0.20) (11), 
pointing out the safety concerns related to the mortality 
risk of LPD. However, this trial involved surgeons who 
had performed 20 or more LPD, while the common 
consensus in literature is that the learning curve for LPD 
is generally 30–50 cases (12,34,61,111,112), and 20 LPD 
may not be sufficient to qualify a surgeon to perform the 
procedure to the required standard. On the other hand, a 
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recent trial by Palanivelu et al. showed that the mortality 
rate after LPD was equivalent to that after OPD (1 of 32 
in each) (14). Hakeem et al. reviewed 12 matched LPD and 
OPD patients and found that the overall mortality rate was 
similar (3% vs. 6%, P=0.283), with only one death within 
30 days in the OPD group (secondary to severe sepsis) and 
none in the LPD group (78). Torphy et al. analyzed 22,013 
patients in the American National Cancer Database who 
had undergone pancreaticoduodenectomy between 2010 
and 2015. Among these, 3,205 patients had undergone 
LPD, and the authors found no significant difference in 30- 
or 90-day mortality between LPD and OPD (9). Kuesters 
et al. found no significant difference in postoperative 
mortality and morbidity between LPD and OPD in their 
series of patients with PDAC (59). Similarly, Khaled 
et al. also found no significant difference in postoperative 
mortality (0% vs. 6.7%, P=0.99) between OPD and LPD in 
a cohort of 30 matched patients (15 LPD vs. 15 OPD) (51). 
LPD is a very difficult and risky operation, but Lu et al. 
indicated that if hospitals have ample clinical experience 
in traditional pancreaticoduodenectomy, up-to-date 
laparoscopic equipment, and strict surgical indications, and 
if the surgeons have meticulous laparoscopic technique 
and a culture of consultation and cooperation, LPD can 
be feasible and safe (113). Low hospital volume has been 
demonstrated to be an important factor related to increased 
postoperative morbidity and mortality (9,12,28,29,114), 
raising the issue of the number of LPD needed at each 
center to reach a relatively safe level. A recent study has 
shown that in pancreatic centers that have performed 10 or 
more LPD, the 30-day mortality rate after a laparoscopic 
procedure was equal to that of the open procedure (0.0% 
vs. 0.7%, P=1.00) (29). In addition, another study revealed 
that the benefits of LPD were hardly observed unless 25 or 
more PD could be implemented per year (28).
Topic 13: LPD in elderly patients
Statement: LPD can be safely performed in elderly patients 
without increasing the risk of postoperative morbidity and 
mortality.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
Whether LPD can be performed safely in elderly 
patients as with conventional OPD is also a concern, 
although age increases the perioperative risk to elderly 
patients, LPD itself was not associated with increased 
morbidity and mortality (68). In fact, Tee et al. reported that 
in elderly patients, OPD has been shown to be associated 
with increased DGE (OR, 1.80, P=0.03), LOS (1 additional 
day, P<0.001) and rate of blood transfusion (OR, 2.89, 
P<0.001), compared with LPD (68). In a study involving 
a large sample of 1,768 elderly (≥75 years) patients, the 
90-day mortality rate was lower in the LPD group than in 
the OPD group (7.2% vs. 12.2%, P=0.049). Of note, the 
median overall survival was also found to be longer in the 
LPD group (19.8 vs. 15.6 months, P=0.022) (115). Elderly 
patients undergoing LPD seem to experience higher 
overall morbidity than younger patients (41% vs. 20%, 
P=0.05). However, in elderly patients who need to undergo 
pancreaticoduodenectomy, the mortality and morbidity 
rates were comparable between these two approaches, 
and LPD might have certain advantages over OPD (116). 
Similarly, several studies have also shown that LPD is safe 
and feasible in elderly patients (43,117,118).
Topic 14: Follow-up after LPD
Statement: Recurrence-free and overall survival after LPD 
are equal to that after OPD, and both procedures achieve 
equivalent rates of radical resection margins and number 
of harvested lymph nodes. Patients who undergo LPD 
experience a more favorable quality of life in the first 6 
months after surgery.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
Young et al. reported a case of port-site recurrence 
following LPD (119). Therefore, it is of great concern 
whether LPD may compromise survival compared with 
OPD. Song et al. retrospectively reviewed the data 
of 500 consecutive patients who underwent LPD at a 
single institution between January 2007 and December 
2017, finding that the 5-year overall survival rates of 
pancreatic, distal common biliary duct, ampulla of 
Vater, and duodenal cancer were 37.4%, 63.2%, 78%, 
and 88.9%, respectively, and the median overall and 
recurrence-free survival following LPD for pancreatic 
cancer was 32.4 and 14.9 months, respectively (47). 
Chen et al. found that patients who underwent LPD had 
similar 1-year (OR, 1.20; 95% CI, 0.87–1.65; P=0.28), 
and 2-year survival (OR, 1.25; 95% CI, 0.94–1.66; 
P=0.13) rates to those who underwent OPD. In contrast, 
the 3-year (OR, 1.50; 95% CI, 1.12–2.02, P=0.007), 
4-year (OR, 1.73; 95% CI, 1.02–2.93, P=0.04), and 
5-year (OR, 2.11; 95% CI, 1.35–3.31, P=0.001) survival 
rates were significantly higher in the LPD group (24). 
Stauffer et al. (22) retrospectively analyzed 251 patients 
that  underwent  PD for  PDAC,  f inding that  the 
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estimated median survival was 20.3 months for OPD and 
18.5 months for LPD. The overall survival rate at 1, 2, 3, 4, 
and 5 years was similar after OPD (68%, 40%, 24%, 17%, 
and 15%, respectively) and LPD (67%, 43%, 43%, 38%, 
and 32%, respectively). Kim et al. studied 149 patients 
with pancreatic neuroendocrine tumors who underwent 
PD. The 3-year overall and disease-free survival rates 
were 91.9% and 94.8% in the LPD group, and 93.6% 
and 86.7% in the OPD group (P=0.974 and 0.225, 
respectively) (120). A meta-analysis performed by Peng 
et al., which included 10 studies with 11,180 patients (1,437 
undergoing LPD and 9,743 undergoing OPD), showed 
that while LPD was associated with longer disease-free 
survival than OPD (hazard ratio, 0.77; 95% CI, 0.61–0.98; 
P=0.033), there was no significant difference in overall 
survival (hazard ratio, 0.98; 95% CI, 0.90–1.07; P=0.672). 
In addition, patients who had undergone LPD had a 
significantly shorter interval between surgery and initiation 
of adjuvant chemotherapy (weighted mean difference 
–10.17; 95% CI, –17.90 to –2.45; P=0.010) (23), implying 
that patients would benefit from receiving chemotherapy 
earlier. Delitto et al. found that overall survival was not 
statistically different between patients undergoing LPD 
and OPD for periampullary adenocarcinoma (median 
overall survival 27.9 vs.  23.5 months; P=0.955) or 
pancreatic adenocarcinoma (median overall survival 20.7 
vs. 21.1 months; P=0.703) (39). Deichmann et al. reported 
a matched pair analysis of 120 patients and discovered 
that patients that underwent LPD showed a trend towards 
improved median overall survival (56 vs. 48 months; 
P=0.056) (103). A Chinese group has previously shown 
that the number of harvested lymph nodes, as well as 1-year 
recurrence-free and overall survival, was not significantly 
different between patients with malignant tumors that 
underwent LPD or OPD (121), which was consistence 
with results from other studies (22,26,53,59,122). A 
further small cohort study by Conrad et al. reported 1-, 3-, 
and 5-year overall survival rates for PDAC patients were 
80.5%, 49.2%, and 39.7%, respectively, in the LPD group, 
compared to 77.8%, 46.4%, and 30%, in the OPD group 
(P=0.41, 0.42, and 0.25). Similarly, the 1-, 3-, and 5-year 
recurrence-free survival rates for PDAC patients were 
70.9%, 33.3%, and 21.9%, respectively, in LPD group, 
and 62.3%, 37.9%, and 25.7% in OPD group (P=0.27, 
0.37, and 0.39), indicating that LPD achieves non-inferior 
survival outcomes (123). Similar findings were reported 
in another large study, where median overall survival for 
PDAC patients was 20.7 months in the LPD group and 
20.9 months in the OPD group (P=0.68) (79). Moreover, 
a recent meta-analysis of 14,017 patients with pancreatic 
cancer demonstrated that overall survival after LPD was 
comparable to that after OPD (hazard ratio, 0.98; 95% CI, 
0.90–1.07; P=0.672). Importantly, recurrence-free survival 
was superior in patients that underwent LPD (hazard 
ratio, 0.77; 95% CI, 0.61–0.98; P=0.033) (23).
Section 5: Surgical training and management of the 
learning curve
Topic 15: Surgical training
Statement: While LPD is a safe and feasible procedure, 
it is technically challenging. Surgeons are encouraged 
to pursue training by means of detailed explanations of 
operative technique, video training, box trainers, virtual 
reality simulators, and proctored practice on porcine models. 
Training to improve surgeons ability to manage psychological 
stress should not be ignored as it would help surgeons 
perform better in challenging clinical situations. With the 
development of computer technology, increasingly more 
advanced digital processors and design features will help 
surgeons achieve better performance. LPD training programs 
should be established at large-volume pancreatic centers with 
a protocol in place to certify appropriately trained surgeons.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
Although studies have shown it to be a safe and feasible 
treatment choice, LPD is indeed a complex and challenging 
procedure. Lack of experience with this approach was 
related to increased postoperative morbidity and mortality 
during the learning curve (124). Therefore, the technical 
training of young surgeons is critically important. As 
the starting point, trainees are encouraged to be familiar 
with traditional pancreaticoduodenectomy (55). Under 
the guidance and feedback of experienced pancreatic 
surgeons, video training, box trainers, and virtual reality 
simulators could be effective tools for surgical education 
and assessment (125-129). Despite the obvious anatomical 
differences, LPD was feasible in a porcine model (40,130), 
giving another useful approach for surgical education. In 
addition, special psychological skills training is helpful for 
teaching surgical trainees to deal with unexpected events 
during surgery (131-134). Surgical instruments that involve 
more advanced digital processors and design features, 
such as grips that enhance tactile feedback, help trainees 
achieve better performance (135,136). Moreover, de Rooij 
et al. recently reported the application of an LPD training 
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program, including detailed explanation of operative 
technique, video training, and proctoring, to 8 surgeons 
from 4 high-volume centers. The program led to the 
achievement of acceptable rates of grade B/C POPF (34%), 
Clavien-Dindo grade ≥III complications (43%), and 90-day 
mortality (3.5%), in all centers (55).
Topic 16: Management of the learning curve
Statement: Surgeons achieve technical competency after 
performing 30 to 50 LPD procedures. Operation time, 
intraoperative blood loss, conversion, postoperative 
complication rate, and LOS are the indicators to be used for 
learning curve assessment.
Quality of evidence: Moderate.
Strength of recommendation: Strong.
The rate of postoperative complications after LPD is 
intimately associated with the learning curve (12,124). 
Data from a previous cohort study showed that surgeons 
reached a learning curve plateau, in terms of operation time 
and blood loss, after performing 10 LPD (137). However, 
regardless of surgical complications and mortality, a 10-case 
learning curve is not entirely convincing. Indeed, another 
cohort study reported a significant reduction in operation 
time within the first 10 cases (61). In fact, operative time 
and blood loss only plateaued at 50 cases (61). In another 
retrospective cohort study, clinical outcomes improved 
after 30 to 60 LPD had been completed, as evidenced by 
a reduction of blood loss, decreased rate of postoperative 
morbidity, and shortened LOS (111).
Moreover, based on a cumulative sum analysis, a 
previous study has demonstrated that the learning curve 
for LPD involves three phases: initial learning (cases 1–11), 
technical competence (cases 12–38), and challenging 
cases (cases 39–57). Progression through the learning is 
evidenced by decreased operation time, blood loss, and 
postoperative ICU stay. Therefore, a minimum of 40 cases 
was recommended for attaining technical competence in 
LPD (112). Similarly, cumulative sum analysis in another 
study identified three learning phases to LPD. However, in 
that study, a minimum of 30 cases of LPD was suggested 
to achieve technical competence (34). According to Wang’s 
recent large, multicenter study, LPD is associated with a 
three-phase learning curve, with proficiency thresholds at 
40 and 104 cases (12).
Conclusions
During the past decades, there have been major advances 
in LPD. The use of such technique has been slowly gaining 
momentum, to the stage now with significant acceptance 
by pancreatic surgeons. Barriers, for instance, lack of 
training, video equipment, proper surgical instrumentation, 
or surgical skill, have gradually been overcome. Although 
operative time is generally longer when performing 
LPD, safety and feasibility are guaranteed in the hands of 
experienced pancreatic surgeons, compared with that of 
OPD. Importantly, the short- and long-term outcomes 
in patients who undergo LPD is equivalent to those who 
undergo OPD. Resource utilization and costs of LPD have 
been deemed to be potential drawback of such technique. 
However, although LPD had higher intraoperative costs, 
taken into account the decreased use of postoperative 
hospital resources and increased postoperative quality of 
life, overall costs could be identical between LPD and 
OPD.
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Country Name Number
China (Mainland) Renyi Qin, Yinmo Yang, Taiping Zhang, Yiping Mou, Xianjun Yu, Bing Peng, Chengfeng Wang, 
Xiujun Cai, Shengquan Zou, Shuyou Peng, Yupei Zhao
11
China (Hongkong) Tan To Cheung 1
China (Macau) Nim Choi, Manson Fok 2
China (Taiwan) Yu-Wen Tien 1
India Chinnusamy Palanivelu, Palanisamy Senthilnathan, Virinder Kumar Bansal 3
Japan Michiaki Unno 1
Korea Ho-Seong Han, Jae Hoon Lee 2
Netherlands Steven W. M. Olde Damink 1
Singapore Pierce Chow 1
UK Rowan Parks 1
USA Michael Kendrick, Christopher Wolfgang, Barish Edil, Jin He 4
Supplementary
Table S2 Summary of recommendations
Domain N Topic Statement
Quality of 
evidence
Grade 
recommendation
Implementation 1 Safety and 
feasibility
LPD is safe and feasible compared with OPD, when performed in large volume medical centers by experienced surgeons. LPD is associated with a longer operative 
time, less intraoperative blood loss, and shorter LOS than OPD, while its overall complication and perioperative mortality rates are equivalent
Moderate Strong
2 Volume of 
pancreatic center 
and LPD
LPD should be carried out in pancreatic center with at least 25 cases of OPD per year. In addition, a robust radiology department and experienced interventionalists, 
as well as the pathology and anesthesiology departments, should also work closely together in order to carry out the surgery successfully
Moderate Strong
3 Surgeon’s 
experience and 
LPD
In order to perform LPD successfully, surgeons should meet the following criteria: (I) surgeons should have advanced laparoscopic skills. Advancement through the 
learning curve of minimally invasive surgery from basic to complex procedures, and mastering basic laparoscopic skills, such as dissection, suturing, and knotting, 
is essential before starting to perform LPD. (II) Experienced in OPD. Surgeons and teams intending to adopt LPD should first be proficient in OPD with each 
individual having a cumulative experience of >50 cases
Moderate Strong
4 Surgical team and 
LPD
The operating surgeon, assistant surgeon, anesthesiologist, and nursing team for LPD should be relatively fixed Low Weak
Indications, 
contraindications, 
and preoperative 
preparation
5 Indications Indications of LPD could be similar to those of OPD, and should be determined by a MDT discussion before surgery, with careful consideration of the stage of the 
learning curve at which the surgeon is located
Moderate Strong
6 Contraindications Contraindications of LPD could be similar to those of OPD, in addition to some laparoscopic contraindications Moderate Weak
7 Preoperative 
preparation
The preoperative preparation for LPD patients are consistent with those for OPD patients. Surgeons per se should also be prepared with proficient surgical skills for 
reducing the rate of conversion to laparotomy
Moderate Strong
Technique 8 Types of LPD There are four types of LPD: total, hand-assisted, laparoscopy-assisted, and robotic-assistance. Each is defined below. The choice of operative approach should be 
made in accordance with the stage of learning cure at which the surgeon is located. Robotic surgery for LPD may offer several advantages, especially for digestive 
tract reconstruction. However, due to its high cost, it is not widely utilized
Moderate Strong
9 The approach to 
resection during 
LPD
The principles of tumor resection by LPD should be similar to those of standard OPD for different types of cancer. Short-term oncologic outcomes (harvested lymph 
nodes/positive resection margins) are comparable between LPD and OPD
Moderate Strong
Technique 10 Gastrointestinal 
reconstruction 
during LPD
The reconstruction phase during LPD is especially technically demanding and time-consuming, taking longer than that during OPD. However, the morbidity 
associated with gastrointestinal reconstruction is comparable between LPD and OPD
Moderate Strong
Postoperative 
management and 
follow-up
11 Postoperative 
morbidity
LPD, although complicated and technically demanding, is safe and effective in the hands of experienced surgeons. The rate of complications in patients who 
undergo LPD is equivalent to those who undergo OPD. Moreover, patients benefit from the laparoscopic approach with respect to reduced blood loss and surgical 
site infections, and a shortened hospital stay
High Strong
12 Postoperative 
mortality
The mortality rate after LPD is a significant safety concern. Therefore, LPD should only be performed by skilled laparoscopic surgeons with proper training in high-
volume pancreatic centers. Further large trials involving well-trained laparoscopic surgeons at high-volume hospitals are needed to clarify this concern
Moderate Strong
13 LPD in elderly 
patients
LPD can be safely performed in elderly patients without increasing the risk of postoperative morbidity and mortality Moderate Strong
14 Follow-up after 
LPD
Recurrence-free and overall survival after LPD are equal to that after OPD, and both procedures achieve equivalent rates of radical resection margins and number 
of harvested lymph nodes. Patients who undergo LPD experience a more favorable quality of life in the first 6 months after surgery
Moderate Strong
Surgical training and 
management of the 
learning curve
15 Surgical training While LPD is a safe and feasible procedure, it is technically challenging. Surgeons are encouraged to pursue training by means of detailed explanations of 
operative technique, video training, box trainers, virtual reality simulators, and proctored practice on porcine models. Training to improve surgeons ability to 
manage psychological stress should not be ignored as it would help surgeons perform better in challenging clinical situations. With the development of computer 
technology, increasingly more advanced digital processors and design features will help surgeons achieve better performance. LPD training programs should be 
established at large-volume pancreatic centers with a protocol in place to certify appropriately trained surgeons
Moderate Strong
16 Management of 
the learning curve
Surgeons achieve technical competency after performing 30 to 50 LPD procedures. Operation time, intraoperative blood loss, conversion, postoperative 
complication rate, and LOS are the indicators to be used for learning curve assessment
Moderate Strong
LPD, laparoscopic pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; LOS, length of stay; MDT, multidisciplinary team.
